Discover the best open-source vulnerability scanners of 2026 that help CIOs minimize security costs while ensuring robust protection against software vulnerabilities. Learn about their features and ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Candidates appearing for GATE 2027 Computer Science and Information Technology (CS) can opt for a second test paper from a ...
Y Combinator has open-sourced the QM agent harness to help startups build isolated team workspaces. Store session history safely in PostgreSQL.
Microsoft's seventh .NET 11 preview expands runtime-async, developer tooling, libraries, C#, Blazor, MAUI, EF Core and Windows Forms.
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Recursion Pharmaceuticals insiders reported 6 transactions totaling $589,430.56. Activity included 2 tax payments, 2 sales, and 2 stock awards between July and August 2026. View more Major Holders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results